Irvine-based lens maker LensGen Inc. closed a $21 million series A financing with an option to expand the financing commitment by an additional $5 million.
The financing was led by the corporate venture investment arm of technology and med-tech company HOYA Group in Tokyo, Japan and included participation from Relativity Healthcare Partners.
LensGen develops implantable intraocular lens for patients with presbyopia, an age-related vision condition in which the eye loses its flexibility, making it difficult to focus on close objects.
The medical device company makes a lens that’s designed to mimic the eye’s ability to change shape—curvature—and adjust focus.
— Sherry Hsieh
